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Purpose: The gene for Eph-receptor tyrosinekinase-type A2 (EPHA2) has been shown to be involved in the pathogenesis
of age-related cataract (ARC). The aim of this study was to examine whether EPHA2 polymorphisms were associated
with the susceptibility to age-related cortical cataract in a Han Chinese population.
Methods: Five single-nucleotide polymorphisms (SNPs)—rs3768293, rs3754334, rs7548209, rs707455, and rs477558
—in the EPHA2 gene were genotyped in 422 Han Chinese patients with age-related cortical cataract and 317 age-, sex-,
and ethnically matched healthy controls using a PCR restriction fragment length polymorphism (PCR-RFLP) assay. Data
were analyzed by χ2 analysis.
Results: The results showed that the five analyzed polymorphisms in EPHA2 were in Hardy–Weinberg equilibrium both
in the patients and in the controls. The frequency of the rs477558 AA genotype was signiﬁcantly increased in ARC patients
compared with controls (χ2=8.69, pc=0.045, odds ratio [OR] 1.555, 95% CI 1.158 to 2.089). The frequency of the
rs477558 AG genotype was signiﬁcantly decreased in ARC patients compared with controls (χ2=9.281, pc=0.030, OR
0.626, 95% CI 0.463 to 0.847). Signiﬁcantly higher frequencies of the GG genotype and the G allele of rs7548209 were
observed in ARC patients compared with controls (χ2=10.430, pc=0.015, OR 1.660, 95% CI 1.219 to 2.261 and χ2=8.537,
pc=0.015, OR 1.486, 95% CI 1.138 to 1.940, respectively). On the other hand, signiﬁcantly decreased frequencies of the
rs7548209 CG genotype and the C allele were observed in ARC patients compared with controls (χ2=9.999, pc=0.030,
OR 0.603, 95% CI 0.440 to 0.826 and χ2=8.537, pc=0.015, OR 0.673, 95% CI 0.515 to 0.879, respectively). There was
no difference in the frequencies of the genotype and allele of the rs3768293, rs3754334, and rs707455 SNPs between the
patients with ARC and the controls.
Conclusions: Our study suggests that both SNP rs477558 and SNP rs7548209 of EPHA2 are associated with age-related
cortical cataract in a Han Chinese population.
Cataract  is  the  leading  cause  of  visual  impairment
worldwide, with approximately 37 million people affected,
accounting  for  48%  of  global  blindness  and  with
approximately half of all cases originating in Africa and Asia
[1,2]. Approximately 80% of all cataracts are age-related and
idiopathic [3]. Age-related cataract (ARC) has been deﬁned
as the appearance of the clinical sign of cataracts in one or
both eyes in a person older than 50 years [4]. ARC accounts
for 18 million cases of blindness and 59 million cases of
reduced vision worldwide [5]. Depending on the location of
the  opacity  within  the  lens,  age-related  cataracts  can  be
divided  into  four  categories:  nuclear,  cortical,  posterior
subcapsular, and mixed type [6]. The development of ARC is
complex and multi-factorial, where genetic predisposition and
environmental elements both contribute to the pathological
condition.  Family  epidemiological  investigations  have
showed that hereditary factors play an important role in the
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occurrence of ARC [7-11]. Moreover, it is known that cortical
cataract is highly heritable among four types of age-related
cataract [10,11]. Over the past several years, to have better
comprehension of the molecular processes that are associated
with  cataract  development,  attempts  have  been  made  to
identify the genes and characterize the proteins they encode
[3,12-18].  However,  the  exact  genetic  mechanism  and
pathogenesis of age-related cataract remain unclear.
Eph-receptor tyrosinekinase-type A2 (EPHA2) encodes
a  976  amino  acid,  type-1  transmembrane  protein  with
extracellular NH2-terminal and cytoplasmic COOH-terminal
halves [19] and is a member of the largest sub-family of
receptor tyrosine kinases. The human EPHA2 gene is located
on  chromosome  1p36,  where  linkage  with  autosomal
dominant and autosomal recessive cataracts has been reported
[20-24]. Recently, several EPHA2 variants were found to be
associated  with  age-related  cortical  cataracts  in  different
worldwide  Caucasian  populations  [5,13,25].  Furthermore,
accumulated evidences have shown that genetic heterogeneity
existed in different ethnic cohorts. Therefore, we examined
whether  EPHA2  polymorphisms  were  associated  with  the
susceptibility  to  age-related  cataract  in  a  Han  Chinese
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1553population.  In  this  study  we  found  that  single-nucleotide
polymorphisms (SNPs) rs477558 and rs7548209 in EPHA2
were associated with age-related cortical cataract in a Han
Chinese population.
METHODS
Subjects: The study adhered to the tenets of the Declaration
of Helsinki. All participants signed the respective informed
consent  forms.  The  research  was  approved  by  the  Ethics
Committee of Research Institute of Field Surgery, Da Ping
Hospital, Third Military Medical University, Chongqing, P.R.
China. The subjects were 422 sporadic Han Chinese patients
with age-related cortical cataracts and 317 normal controls.
All  subjects  were  unrelated  Chinese  individuals  recruited
from  the  Research  Institute  of  Field  Surgery,  Da  Ping
Hospital, Third Military Medical University, Chongqing, P.R.
China,  from  March  2010  to  March  2011.  Patients  with
secondary  cataracts  caused  by  persistent  intraocular
inflammation,  trauma,  uveitis,  high  myopia,  glaucoma,  or
degenerated ocular diseases were excluded from this study.
Information  on  hypertension,  diabetes  mellitus,  prolonged
corticosteroid administration, and other known causes were
not available. Controls were individuals who visited the same
hospital for a routine ophthalmic examination and were age-,
sex-,  and  ethnically  matched  with  the  ARC  patients.  The
control group included unrelated healthy individuals without
history of cataract, hypertension, diabetes, tumor, or other
ocular diseases. Baseline characteristics of study participants
are shown in Table 1. All ARC patients and control subjects
underwent a full ophthalmic examination, including visual
acuity, lens examination in transient and side illumination
with  a  slit  lamp  biomicroscope  after  mydriasis,  and
ophthalmoscopic examination. The degrees of cataract in all
patient eyes were CII or CIII according to the Lens Opacities
Classification System, version II (LOCS II) [26]. The degrees
of nuclear hardness in all eyes were equal to or more than
grade III according to the Emery and Little nuclear hardness
classification.  All  the  patients  then  received
phacoemulsification  and  intraocular  lens  implantation
surgery.
Blood samples and DNA extraction: Venous blood samples
were obtained from the ARC patients and controls in EDTA
Vacutainers (BD, Franklin Lakes, NJ). Genomic DNA was
extracted from peripheral venous blood using a QIAamp DNA
Blood Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. DNA samples were collected in
1.5 ml Eppendorf tubes and stored at −20 °C until used. DNA
concentrations  were  measured  by  NanoDrop  2000
Spectrophotometer  (NanoDrop  Technologies,  Wilmington,
DE).
SNP selection and genotyping: The SNPs were selected from
earlier studies on the association of EPHA2 polymorphisms
with age-related cataract in other ethnic groups [5,13]. We
therefore  selected  rs3768293,  rs3754334,  rs477558,
rs707455, and rs7548209 as candidate SNPs. Ampliﬁcation
of the target DNA in EPHA2 was analyzed by polymerase
chain reaction (PCR) using primers presented in Table 2. Each
PCR  reaction  was  performed  in  a  10  μl  reaction  mixture
containing  5  μl  Premix  Taq  (Ex  Taq  Version;  TaKaRa
Biotechnology Co. Ltd., Dalian, China), 20 pmol primers, and
0.2 μg of genomic DNA for ampliﬁcation of the DNA. The
conditions were as follows: initial denaturation at 95 °C for 5
min followed by 38 cycles of denaturation at 94 °C for 30 s,
annealing at different temperatures (54 °C for rs3768293 and
rs3754334, 56 °C for rs477558, and 60 °C for rs707455 and
rs7548209) for 30 s, extension at 72 °C for 30 s, and a ﬁnal
extension at 72 °C for 5 min. These SNPs were genotyped by
PCR-restriction  fragment  length  polymorphism  analysis.
PCR  products  of  rs3768293,  rs3754334,  rs477558,
rs707455, and rs7548209 polymorphisms were respectively
digested with 4 U of Tru1I (MBI Fermentas, Burlington, ON,
Canada), TasI (MBI Fermentas), AluI (Promega, Madison,
WI),  HpyF10VI  (Promega),  and  Hsp92II(Promega)
restriction enzymes (Table 2) in a 10  μl reaction volume
overnight.  Digestion  products  were  visualized  on  a  4.0%
agarose  gel  and  stained  with  GoldView  (SBS  Genetech,
Beijing,  China).  Direct  sequencing  was  performed  by
Invitrogen Biotechnology Company (Shanghai, China) using
the  randomly  selected  subjects  (20%  of  all  samples)  to
validate the method used in this study.
Statistical analysis: Hardy–Weinberg equilibrium was tested
using the χ2 test. The number of genotypes and alleles were
obtained by direct counting. Allele and genotype frequencies
were compared between ARC patients and controls by the χ2
test using SPSS (version 17.0, SPSS, Inc., Chicago, IL). The
p values were corrected (pc) with the Bonferroni correction
by  multiple  comparisonV with the numbers of analyses
performed. Statistical significance was reached if pc<0.05.
TABLE 1. BASELINE CHARACTERISTICS OF STUDY PARTICIPANTS.
    Sex Age (years)
Group n Male n (%) Female n (%) Mean±SD Range
ARC patients 422 183 (43.36) 239 (56.64) 63.58±6.76 50–89
Controls 31 1 (47.±
               ARC, age-related cortical cataract
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The results showed that the five analyzed EPHA2 genetic
variants were in Hardy–Weinberg equilibrium in both the
ARC patients and the controls. No difference was found in the
distribution of the age and gender ratio between ARC patients
and controls. The distributions of genotypic frequencies and
allelic frequencies of the five tested EPHA2 polymorphisms
are shown in Table 3.
The results showed that there were signiﬁcant differences
between the ARC patients and the controls in the genotype or
allele frequencies of rs477558 and rs7548209. The frequency
of the AA genotype of rs477558 was signiﬁcantly increased
in ARC patients compared with controls (χ2=8.649, pc=0.045,
odds ratio [OR] 1.555, 95% CI 1.158 to 2.089). The frequency
of the rs477558 AG genotype was signiﬁcantly decreased in
ARC patients compared with controls (χ2=9.281, pc=0.030,
OR  0.626,  95%  CI  0.463  to  0.847).  Signiﬁcantly  higher
frequencies  of  the  GG  genotype  and  the  G  allele  of
rs7548209 were observed in ARC patients compared with
controls (χ2=10.430, pc=0.015, OR 1.660, 95% CI 1.219 to
2.261 and χ2=8.537, pc=0.015, OR 1.486, 95% CI 1.138 to
1.940,  respectively).  On  the  other  hand,  signiﬁcantly
decreased frequencies of the rs7548209 CG genotype and the
C  allele  were  observed  in  ARC  patients  compared  with
controls (χ2=9.999, pc=0.030, OR 0.603, 95% CI 0.440 to
TABLE 2. PRIMERS AND RESTRICTION ENZYMES USED FOR RFLP ANALYSIS OF THE EPHA2 GENE.
rs number Primers Restriction enzyme
rs3768293 5′-CAGCTTTCTGGAGTCTCAGTTTTATT-3′ Tru1I
  5′-TCCCTACGTTATATGAGTACCC-3′  
rs3754334 5′-CCCGGCCACCAGAAGCGCAT-3′ TasI
  3′-GACCTCGGGGTAGCCGGTTCTT-5′  
rs477558 5′-ATAAAGATGTGGCTAGAGGT-3′ AluI
  3′-TGCGTAAGTCGTTTCCACCT-5′  
rs707455 5′-CTGATGTAGATGGGGTGCTG-3′ HpyF10VI
  3′-TTTTACCTACACTCTCCGAC-5′  
rs7548209 5′-GGAGAATGGTTTTTAGGAAGCAACAT-3′ Hsp92II
  3′-TTATTTCAAAGGGGAGGACGGT-5′  
TABLE 3. FREQUENCIES OF GENOTYPES AND ALLELES OF EPHA2 POLYMORPHISMS IN ARC PATIENTS AND CONTROLS.
SNP Genotype
allele
ARC (%)
(n=422)
Controls (%)
(n=317)
χ2 p value pc value OR (95% CI)
rs3768293 AA 314 (74.41) 210(66.25) 5.845 0.016 NS 1.481 (1.076~2.039)
  AC 96 (22.75) 99 (31.23) 6.704.  NS.648 (0.467~0.901)
  CC 12 (2.84) 8 (2.52) 0.0.7911S.130 (0.457~2.799)
  A 724 (85.78) 519 (81.86) 4.162 0.041 NS 1.337 (1.011~1.768)
  C 120 (14.22) 115 (18.14) 4.162 0.041 NS 0.748 (0.566~0.989)
rs3754334 CC 301 (71.33) 222 (70.03) 0.147 0.702 NS 1.065 (0.773~1.466)
  CT 111 (26.30) 84 (26.50) 0.004 0.953 NS 0.990 (0.71~1.378)
  TT 10 (2.37) 11 (3.47) 0.1S.6 (0.2~1.)
  C 713 (84.48) 528 (83.28) 0.386 0.534 NS 1.093 (0.826~1.445)
  T 131 (15.52) 106 (16.72) 0.386 0.534 NS 0.915 (0.692~1.211)
rs477558 AA 260 (61.61) 161 (50.79) 8.649 0.003 0.045 1.555 (1.158~2.089)
  AG 135 (31.99) 136 (42.90) 9.281 0.002 0.030 0.626 (0.463~0.847)
  GG 27 (6.40) 20 (6.31) 0.002 0.961 NS 1.015 (0.558~1.845)
  A 655 (77.61) 458 (72.24) 5.607 0.018 NS 1.332 (1.050~1.689)
  G 189 (22.39) 176 (27.76) 5.607 0.018 NS 0.751 (0.592~0.952)
rs707455 TT 218 (51.66) 183 (57.73) 2.687 0.101 NS 0.782 (0.583~1.049)
  CT 178 (42.18) 122 (38.48) 1024.3111S.166 (0.866~1.570)
  CC 26 (6.16) 12 (3.79) 2.094.1481S.669 (0.829~3.361)
  T 614 (72.75) 488 (76.97) 3.404 0.065 NS 0.799 (0.629~1.014)
  C 230 (27.25) 146 (23.03) 3.404 0.065 NS 1.252 (0.986~1.590)
rs7548209 GG 302 (71.56) 191 (60.25)0.001.015.660 (1.219~2.261)
  CG 110 (26.07) 117 (36.91) 9.999 0.002 0.030 0.603 (0.440~0.826)
  CC 10 (2.37) 9 (2.84) 0.159.691S.831 (0.333~2.069)
  G 714 (84.60) 499 (78.71) 8.537 0.003 0.015 1.486 (1.138~1.940)
  C 130 (15.40) 135 (21.29) 8.537 0.003 0.015 0.673 (0.515~0.879)
               OR, odds ratio; pc, Bonferroni corrected p value; NS, not significant.
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Increased frequencies of the AA genotype and the A
allele of rs3768293 were also observed in patients with ARC
compared with normal controls (χ2=5.845, p=0.016, OR1.481,
95%CI 1.076 to 2.039 and χ2=4162, p=0.041, OR1.337, 95%
CI 1.011 to 1.768, respectively). However, the difference was
lost when the Bonferroni correction was performed (pc=0.240
and pc=0.,Uespectively),  andWhere wasQoGifferenceLn
the frequencies of the rs3754334 and rs707455 SNPs between
the ARC patients and the controls.
Haplotype analysis was performed by SHEsis platform
[27],  and  no  significant  association  was  found  between
haplotype and ARC.
DISCUSSION
In this study we focused on the polymorphisms of EPHA2,
which have been shown to affect its expression level and the
clinical presentation of ARC [5,13], and we performed a case-
control association study for these polymorphisms with ARC
in a Han Chinese population. The results showed that SNP
rs477558  and  SNP  rs7548209  were  associated  with  the
susceptibility to age-related cortical cataract.
EPHA2  belongs  to  the  largest  sub-family  of  receptor
tyrosine kinases, and the Eph receptors and their membrane-
anchored  ephrin  ligands  form  cell-contact-dependent
bidirectional  signaling  pathways  affecting  diverse  cellular
processes  including:  actin  cytoskeleton,  cell-substrate
adhesion, cell shape and cell movement, cell proliferation,
survival, and differentiation [28-31]. Previous studies have
shown  that  the  EPH/ephrin  system  is  critical  for  vision
processes in the midbrain [32] and for neural development
[33], and it was recently reported that ephrin-A5, a ligand of
EPHA2, acts as a regulator for EPHA2, and loss of ephrin-A5
function can lead to cataract by disrupting lens fiber cell-
packing in mice [34]. In 2009 [5], it was demonstrated that
cytoplasmic trapping was likely to interrupt both signaling
and structural functions of EPHA2/ephrinA system in lens
fiber cells. Furthermore, cataractogenesis in EphA2 knockout
mice implied that EphA2 was essential for maintaining lens
clarity [5]. In addition, genetic variants of the EPHA2 gene
were identified to confer risks for age-related cortical cataracts
in a Caucasian population [5]. The association of EPHA2 with
age-related cataracts in Caucasians prompted us to investigate
its association with ARC in the Han Chinese population.
Our  results  showed  that  the  rs7548209  SNP  was
positively  associated  with  ARC  in  the  Han  Chinese
population. This result is consistent with earlier findings of
ARC studies in three worldwide Caucasian populations [5].
We also detected an association between the rs477558 SNP
and ARC, a result which is in agreement with earlier findings
reported in an ARC study of a Northern Italian population
[13].  Meta-analysis  showed  a  strong  association  of
rs3768293 and rs3754334 in the EPHA2 gene with ARC in
three  worldwide  Caucasian  populations  [5].  In  addition,
rs707455 has been reported to be associated with ARC in the
Northern Italian population [13]. Our study failed to find an
association of the aforementioned three SNPs with ARC. On
the  other  hand,  two  SNPs in EPHA2, rs6603867  and
rs6678616,  have  been  investigated  for  their  significant
association with ARC in the different Caucasian groups [5].
As  rs6678616  is  not  polymorphic  and  the  minor  allele
frequency  of  rs6603867  is  low  (5%)  in  the  Han  Chinese
population according to the International HapMap data, they
were ﬁnally excluded in this study. Taken together, these
results suggest that SNP-based allele frequencies and thereby
association  with  a  disease  phenotype  often  vary  among
different ethnic groups.
As  association  studies  may  be  influenced  by  many
factors, the following measures were used to validate the
results. First, only patients with primary cortical cataracts who
underwent lens extraction were included in the present study.
If there was any doubt, patients were excluded from the study.
Then, unrelated healthy individuals were selected from the
same geographical regions as the ARC patients. The patients
and controls were age-, sex-, and ethnically matched. Finally,
20% of the samples were randomly chosen and analyzed by
direct sequencing in an attempt to validate the PCR-RFLP
data.
As with other candidate gene studies, there are several
limitations in our study. First, as the power to detect disease
susceptibility genes is influenced by the number of patient
samples, the size of the patient sample group in our study
seemed to be relatively small, and the patients were recruited
only from the Han Chinese population. The results observed
in this study need to be confirmed using larger sample sizes
and other ethnic populations. Second, the biologic functions
of  rs477558  and  rs7548209,  two  associated  SNPs
demonstrated in our study, need to be further investigated.
Third,  age-related  cataract  is  termed  as  nuclear,  cortical,
posterior  subcapsular,  or  mixed  cataract  by  the  zone  of
opacification. In this study, we included only cortical cataract
cases. The association of SNPs in EPHA2 might account for
all  types  of  ARC,  so  our  study  also  needs  to  detect  the
association of EPHA2 with the other three types.
In  conclusion,  our  study  identiﬁed  the  association  of
rs477558 and rs7548209 in EPHA2 with age-related cortical
cataract in a Han Chinese population. A large number of well
matched  samples,  multiple  ethnic  groups,  and  further
functional  studies  will  contribute  to  the  understanding  of
genetic  predisposition  to  risk  of  ARC,  identiﬁcation  of
disease-causing variants, and knowledge of the underlying
mechanisms by which disease-causing variants affect disease
susceptibility. To our knowledge, the present study is the first
report of a Han Chinese population on the association of
EPHA2 with age-related cortical cataract.
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